130145-46-9

Upstream product

• 54321-79-8 4-amino-3,5-dinitrobenzamide 
• 7221-27-4 4-amino-3,5-dinitrobenzoic acid 
• 1072919-85-7 4-amino-3,5-dinitro-benzoyl chloride 
• 467443-76-1 2-Chloro-5-isocyanato-1,3-dinitro-benzene 
• 130145-34-5 methyl (4-chloro-3,5-dinitrophenyl)carbamate 
• 130145-33-4 4-chloro-3,5-dinitro-benzoyl azide 
• 130145-45-8 4-amino-3,5-dinitro-1-(methoxycarbonylamino)benzene 

Downstream Products

• 1072919-41-5 7-amino-5-methoxycarbonylamino-2-(4-bromo-phenyl)-1H-benzo[d]imidazole 

Relevant academic research and scientific papers

Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents

Libraries of novel trisubstituted benzimidazoles were created through rational drug design. A good number of these benzimidazoles exhibited promising MIC values in the range of 0.5-6 μg/mL (2-15 μM) for their antibacterial activity against Mtb H37Rv strai

BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF

The present invention relates to novel benzimidazole derivatives and pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating a patient infected by Mycobacterium tuberculosis or Francisella tulerensis by ad

Potential Antimitotic Agents. Synthesis of Some Ethyl Benzopyrazin-7-ylcarbamates, Ethyl Pyridopyrazin-7-ylcarbamates, and Ethyl Pyrido-as-triazin-7-ylcarbamates

Ring analogues and derivatives of the 1,2-dihydropyridopyrazin-7-ylcarbamates (e.g., 29), antimitotic agents with antitumor activity, were prepared in the search for compounds with greater selectivity.Methods were developed for the conversion of su